GlobeNewswire 2014-07-01 Sobi awarded Company of the Year at the European Mediscience Awards 2014
GlobeNewswire 2014-06-25 Sobi files for EU approval of Xiapex for Peyronies disease
GlobeNewswire 2014-06-16 Sobi to review preclinical data to potentially add future haemophilia A candidate to collaboration a...
GlobeNewswire 2014-06-09 The US Food and Drug Administration (FDA) approves Eloctate(TM)
GlobeNewswire 2014-06-05 Sobi Establishes North American Office in Massachusetts
GlobeNewswire 2014-05-26 Swedish Orphan Biovitrum AB (publ): Sobi appoints Kirsti Gjellan as Senior Vice President Manufactur...
GlobeNewswire 2014-05-12 Biogen Idec and Sobi to donate 1 billion international units of clotting factor to support treatment...
GlobeNewswire 2014-05-08 Swedish Orphan Biovitrum AB (publ): Resolutions from Sobi's AGM
GlobeNewswire 2014-05-08 Swedish Orphan Biovitrum AB (publ): Annette Clancy joins Sobi's Board of Directors
GlobeNewswire 2014-05-08 Sobi publishes Report for the First Quarter 2014
GlobeNewswire 2014-04-30 Invitation - Presentation of Sobi's first quarter results 2014
GlobeNewswire 2014-04-16 Sobi publishes Annual Report 2013
GlobeNewswire 2014-04-14 Auxilium and Sobi announce encore presentation of Xiapex data at European Association of urology con...
GlobeNewswire 2014-04-10 Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric ...
GlobeNewswire 2014-04-07 Sobi becomes market authorisation holder for Xiapex in Europe
GlobeNewswire 2014-04-03 Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
GlobeNewswire 2014-04-03 Sobi enters partnership with Tigenix for the commercialisation of ChondroCelect
GlobeNewswire 2014-04-01 Sobi assumes direct responsibility for Orfadin® (nitisinone) in US and Canada and introduces Orfadin...
GlobeNewswire 2014-03-31 Sobi: US FDA approves Alprolix(TM)
GlobeNewswire 2014-03-26 Sobi: Kiobrina pivotal phase 3 study did not meet primary endpoint
GlobeNewswire 2014-03-25 Cometriq® approved in Europe for the treatment of progressive, unresectable locally advanced or meta...
GlobeNewswire 2014-03-21 Health Canada approves Alprolix(TM)
GlobeNewswire 2014-02-26 Sobi receives EURORDIS Company Award 2014
GlobeNewswire 2014-02-20 Sobi publishes its Report for the Fourth Quarter and Full Year 2013
GlobeNewswire 2014-02-10 Invitation - Presentation of Sobi's fourth quarter and full year results 2013